ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 243,56
0,68%
Dow Jones
39 387,76
0,00%
DAX
18 804,98
0,67%
Brent Oil
84,045
0,11%
Bitcoin
63 267,20
0,35%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kinnate Biopharma Inc (KNTE)

  7. Kinnate Biopharma Inc (KNTE) Actualités

KNTE Kinnate Biopharma Inc

2,65
0,00 (0,00%)
Avant marché
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Kinnate Biopharma Inc KNTE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,65 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,65
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/4/202415:00GLOBEXOMA Corporation Announces Closing of Tender Offer
19/3/202421:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
05/3/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:27EDGAR2Form SC 14D9 - Solicitation, recommendation statements
01/3/202414:53EDGAR2Form SC14D9C - Written communication relating to third party..
01/3/202414:50EDGAR2Form 8-K - Current report
01/3/202414:35PRNUSKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
01/3/202414:30GLOBEKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
21/2/202412:01EDGAR2Form SC14D9C - Written communication relating to third party..
16/2/202423:57PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
16/2/202416:46PRNUSKuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to..
16/2/202415:10EDGAR2Form 8-K - Current report
16/2/202414:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16/1/202422:05EDGAR2Form 8-K - Current report
05/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:00EDGAR2Form 8-K - Current report
09/11/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:14EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEKinnate Biopharma Inc. Reports Third Quarter 2023 Financial..
18/9/202322:28EDGAR2Form 8-K - Current report
18/9/202322:10GLOBEKinnate Biopharma Inc. Announces Pipeline Updates, Strategic..
06/9/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:16EDGAR2Form 8-K - Current report
08/8/202322:05GLOBEKinnate Biopharma Inc. Reports Second Quarter 2023 Financial..
28/7/202322:06EDGAR2Form 8-K - Current report
01/6/202322:05GLOBEKinnate Biopharma Inc. to Participate in Upcoming Investor..
11/5/202322:05GLOBEKinnate Biopharma Inc. Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
KNTE
Kinnate Biopharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés